UASt regulatory sequences drive expression of the 34-residue 'ADan' peptide that is produced in patients with familial Danish dementia as a result of processing of a mutated Hsap\ITM2B protein. The peptide is tagged at the N-terminal with the Tag:SS(nec) signal peptide.
Expression of one or two copies of Hsap\ITM2BADan.Scer\UAS.T:SS-nec in the eye, under the control of Scer\GAL4GMR.PF does not result in any toxic effects at 25[o]C.
Expression of Hsap\ITM2BADan.Scer\UAS.T:SS-nec under the control of Scer\GAL4GMR.PF results in a few scattered ommatidia of different sizes, with a lower number of interommatidial bristles than in wild-type. In addition, there is a significant loss of ommatidia in these flies, compared to controls.
Pan-neural expression of Hsap\ITM2BADan.Scer\UAS.T:SS-nec under the control of Scer\GAL4elav.PU does not lead to any climbing defects. However, expression of two copies of Hsap\ITM2BADan.Scer\UAS.T:SS-nec at 28[o]C results in a significant impairment in climbing ability that worsens with age. After 25 days, these flies also exhibit significant defects in phototaxis.